CClinicalTrials.gg
CompletedNCT05309096Updated Nov 15, 2023

Validity and Reliability of the WAL-K Test

An observational study in Cerebral Palsy and Gait Disorders in Children, sponsored by Afyonkarahisar Health Sciences University. Completed at 1 site in Turkey. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-15.

Sponsored by Afyonkarahisar Health Sciences University · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
66
Ages
6 Years to 18 Years
Sex
All
01

Study summary

Adapting the environment in which a child with Cerebral Palsy lives or adapting himself according to the environment facilitates independence in daily life activities. There is a need for practical performance tests to evaluate the gait adaptation of children with cerebral palsy in the clinic. However, no study has been found to evaluate gait adaptation in children with cerebral palsy. Therefore, the aim of the study is to evaluate the validity and reliability of the WALK test, which was previously developed for children with special learning disabilities, in individuals with cerebral palsy.

Read the detailed description

According to the International Classification of Functioning, Disability, and Health, physical, social, and behavioral environmental factors; can affect a child's disability, activity limitations, and participation. Adapting the environment in which a child with Cerebral Palsy lives or adapting himself according to the environment facilitates independence in daily life activities. There is a need for practical performance tests to evaluate the gait adaptation of children with cerebral palsy in the clinic. However, no study has been found to evaluate gait adaptation in children with cerebral palsy. Therefore, the aim of the study is to evaluate the validity and reliability of the WALK test, which was previously developed for children with special learning disabilities, in individuals with cerebral palsy. The study will be conducted by Afyonkarahisar University Faculty of Health Sciences.

02

Conditions studied

  • Cerebral Palsy
  • Gait Disorders in Children

Browse trials for

Keywords

  • cerebral palsy
  • gait
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's enrollment of 66 is close to the median of 63 across 455 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Afyonkarahisar Health Sciences University is the lead sponsor of 107 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants will consist of children diagnosed with diparetic, hemiparetic, quadriparetic cerebral palsy with a functional level of 1, 2, or 3 according to Gross Motor Function Classification System (GMFCS) in Afyonkarahisar Special Education and Rehabilitation Center in Afyonkarahisar province.

Inclusion criteria

  • 6-18 years of age;
  • Diagnosed with Diparetic, Hemiparetic or Quadriparetic cerebral palsy;
  • GMFCS value being ≤3.
  • Communication Function Classification System (CFCS) for individuals with Cerebral Palsy ≤3.
  • Children with a Modified Ashworth Scale (MASH) ≤ 3 for lower extremity muscles
  • Ability to follow verbal commands
  • Ability to recognize colors or numbers
  • Able to walk ≥10 meters independently with or without an assistive device (orthotics or walking aid)

Exclusion criteria

Exclusion Criteria:

  • Presence of serious hearing, vision or cognitive problems,
  • Nerve block injection or orthopedic surgery in the last 6 months (such as Botox injection or muscle lengthening surgery)
  • Joint contracture
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
66 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. WAL-K test

    The WAL-K test evaluates gait adaptation ability in children. A 10 meter long ladder is used for the test. The test is performed in two different conditions: taking only one step or taking two steps towards a target. The individual is video-recorded for the scoring of the test. Scoring records the total time (in seconds) and the total number of errors (tapping a stick, taking the wrong number of steps on a target, or missing a target) to complete the ladder back and forth. A combination score of time and errors is determined (0.5 s penalty is added to the elapsed time for each error). For the test, 1 trial and two formal tests are applied. The highest of the combination scores of the 2 formal tests is determined as the test result.

    Time frame: 15 minutes

07

Study locations

1 site
  • Emel Taşvuran Horata
    Afyonkarahisar, 03030, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05309096
Lead sponsor
Afyonkarahisar Health Sciences University
Responsible party
Emel Taşvuran Horata (PhD; Assistant Professor, Afyonkarahisar Health Sciences University) — Principal investigator
First posted
Apr 4, 2022
Start date
Apr 1, 2022
Primary completion
Jun 1, 2023
Completion
Nov 1, 2023
Last update
Nov 15, 2023

Study contacts

EMEL TAŞVURAN HORATA, PhD
principal investigator · AFSU

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion